Two Sigma Advisers’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
Other funds holding ZYME
EC
RCMNY
BI
PA
VCM
Two Sigma Advisers's ZYME Position: Q1 2026 in Review
Two Sigma Advisers sold out of Zymeworks (ZYME) in Q1 2026, closing a stake of 31,415 shares — an estimated $827K sold.
Two Sigma Advisers first reported a position in ZYME in Q2 2019 and held it in 15 quarters. The position peaked at $19.3M in Q2 2020. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.
- Two Sigma Advisers reported no remaining Zymeworks position as of Q1 2026 after selling out during the quarter.
- Two Sigma Advisers sold 31,415 Zymeworks shares in Q1 2026, an estimated $827K.
- Two Sigma Advisers first reported a position in Zymeworks in Q2 2019 and held it in 15 quarters.
- Two Sigma Advisers's Zymeworks position peaked at $19.3M in Q2 2020.
- 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.
Based on Two Sigma Advisers's 13F filing for Q1 2026.